The Development of Universal Alopecia During Therapy With TNF-α Inhibitors in Patients With Ankylosing Spondylitis: Description of Three Cases

    October 2021 in “ Rheumatology Science and Practice
    M. V. Aristova, Е. М. Agafonova, A. E. Dimitreva, К. V. Sakharova, С. О. Красненко, Ш. Ф. Эрдес
    Image of study
    TLDR TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.
    The document described three clinical cases where patients with ankylosing spondylitis developed universal alopecia (UA) during therapy with TNF-α inhibitors. Universal alopecia is a severe form of alopecia areata, characterized by complete hair loss across the body. The study explored potential mechanisms behind this condition, highlighting the involvement of pro-inflammatory cytokines. This suggested that TNF-α inhibitors, while used to treat certain autoimmune conditions, might trigger or exacerbate hair loss in some patients.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 197 results

    Related Research

    4 / 4 results